文献速递乳腺乳腺X线MRUS

筛查性对比增强乳腺摄影中的非强化不对称:是否需要进一步诊断性检查

Non-enhancing asymmetries on screening contrast-enhanced mammography: Is further diagnostic workup required?
PubMed 文献 · Eur J Radiol · 2024-12-07

该研究回顾性分析了2012年12月至2021年6月间3482次筛查性对比增强乳腺摄影(CEM),识别出106个非强化不对称(NEA),发生率为2.8%。所有NEA随访均无恶性,与强化不对称相比癌症阳性预测值有显著差异(P < 0.05),作者认为仅凭无强化排除恶性可能减少召回率并提高CEM特异度。

要点

  • 筛查CEM中非强化不对称发生率为2.8%,平均大小1.0 ± 0.7 cm。
  • 106个NEA中无一例恶性,而强化不对称组有恶性病例(P < 0.05)。
  • 作者认为仅凭无强化排除恶性可能减少召回率并提高CEM特异度。

核心结论

  • 筛查CEM检出的非强化不对称相对少见,通常用补充乳腺摄影体位和超声检查,均未发现癌症;仅凭无强化排除恶性可能减少患者召回率并提高CEM特异度。

研究设计与样本

  • 对2012年12月至2021年6月间所有筛查性CEM检查进行计算机检索,识别报告NEA的病例,回顾其诊断性检查,并与筛查CEM中强化不对称的癌症阳性预测值进行统计学比较。

关键影像表现/征象

  • NEA分类为不对称83个、局灶性不对称22个、全局性不对称1个,无进展性不对称病例。
  • NEA平均大小1.0 ± 0.7 cm(范围0.3-4.9 cm)。

诊断标准与关键数值

  • 3482次筛查CEM中识别出97例患者的106个NEA,发生率为2.8%。
  • NEA的癌症阳性预测值为0,强化不对称组有癌症,两组比较P < 0.05。

临床应用与阅片要点

  • NEA的诊断性检查包括补充乳腺摄影体位(n=63)、补充体位加超声(n=30)、补充体位加MRI(n=1)及三种方式联合(n=3),共导致4次活检。
  • 作者认为仅凭无强化排除恶性而不进一步检查,可能减少患者召回率并提高CEM特异度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Asymmetries on screening contrast-enhanced mammography (CEM) often lead to patient recall. However, in diagnostic settings, negative CEM has effectively classified these as normal or benign, questioning the need for further workup of non-enhancing asymmetries (NEAs).

MATERIAL AND METHODS: A computational search of all screening CEM examinations performed between December-2012 and June-2021 was conducted to identify cases reporting NEAs. Their diagnostic workup was reviewed, and the positive predictive value for cancer was statistically compared to that of enhancing asymmetries on screening CEMs.

RESULTS: During the study period, 97 cases of 106 NEAs were identified among 3,482 screening CEM exams (2.8 %). NEAs were classified as asymmetry (n = 83), focal asymmetry (n = 22), and global asymmetry (n = 1), with no cases of developing asymmetry. The mean size of NEAs was 1.0 ± 0.7 cm (range: 0.3-4.9 cm). Diagnostic workup for NEAs included additional mammographic views (AMV) (n = 63), AMV plus ultrasound (n = 30), AMV plus MRI (n = 1), and all three modalities (n = 3), leading to four biopsies. None of the NEAs were malignant on follow-up, as opposed to enhancing asymmetries (P < 0.05).

CONCLUSION: NEAs detected on CEM were relatively uncommon and were usually investigated with additional mammographic views and US, yielding no cancer. Ruling out malignancy based on lack of enhancement without further workup may reduce patient recall rates and improve CEMs specificity.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Nissan N, Reiner JS, Mango VL, et al. Non-enhancing asymmetries on screening contrast-enhanced mammography: Is further diagnostic workup required? Eur J Radiol. 2024. PMID: 39674099. doi:10.1016/j.ejrad.2024.111883

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。